Release Date: 18/06/15 14:17 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 95.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%